SpectraCure AB Stock Nasdaq Stockholm

SPEC BTU

SE0029630789

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 12:00:00 2026-08-14 EDT			5-day change	1st Jan Change
0.0274 ^SEK	+1.48%		-15.17%	-

07-16	Calendar, Thursday, July 16	FW
06-18	Boule Diagnostics appoints Johan Folkunger as new CEO	FW

SpectraCure AB (publ) is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in cancer treatment technology. The Company develops photodynamic therapeutics based on photosensitive materials activated by laser. The Company's method is called interstitial photodynamic therapy (PDT). Interstitial PDT can be used for solid tumors in internal organs, such as cancer in the prostate, pancreas, and the head and neck area, among others. In addition, the Company offers software platform IDOSE for interstitial PDT treatment of solid cancer tumors in internal organs. With SpectraCureâ€™s interstitial PDT method, the patient is given a photoactivated drug - photosensitizer in combination with laser light guided by a dose control system.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-08-14	SEK 0.0274	+1.48%	2,013,745
26-08-13	SEK 0.0270	-5.92%	11,797,089
26-08-12	SEK 0.0287	-18.23%	13,715,785
26-08-11	SEK 0.0351	-2.50%	1,830,134
26-08-10	SEK 0.0360	+11.46%	3,752,388

Delayed Quote Nasdaq Stockholm

More quotes

Income Statement and Estimates

More financial data

Market Cap	20.48M 2.15M 1.86M 1.75M 1.59M 2.99M 206M 3.04M 8.01M 103M 8.09M 7.91M 343M	P/E 2024	-10.6x	P/E 2025	-0.79x
Enterprise Value	9.75M 1.03M 885K 832K 757K 1.42M 98.02M 1.45M 3.81M 49.09M 3.85M 3.77M 163M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	28.39%	Yield 2024 *	-	Yield 2025	-

07-16	Calendar, Thursday, July 16	FW
06-18	Boule Diagnostics appoints Johan Folkunger as new CEO	FW
06-12	Seven stocks hit new 52-week lows on the Stockholm Stock Exchange today	FW
06-01	Spectracure appoints Fata Mrsic as CFO	RE
05-27	SpectraCure Q1 net loss after tax SEK 6.1 mln	RE
05-27	SpectraCure AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-27	Calendar Wednesday May 27	FW
05-26	Calendar Wednesday May 27	FW
05-05	SpectraCure AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-04	SpectraCure AB Auditor Raises 'Going Concern' Doubt	CI
04-22	Six stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
04-15	Seven stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW
04-14	Five stocks hit new 52-week lows on the Stockholm Stock Exchange so far today	FW

12-01	SpectraCure : Interview with CEO Johannes Swartling and Jörgen Wennberg, Chairman of the Board	PU
24-02-23	SpectraCure takes the next step in the work with the new clinical study	AQ
24-01-23	A well-accomplished annual audit in accordance with ISO 13485:2016	AQ
23-12-19	Expert group comments on results of ongoing study	AQ
23-11-29	SpectraCure : Masoud Khayyami presents SpectraCure at investor meetingon November 5 in Lund!	PU

1 week	0.03	0.04
1 month	0.03	0.04
Current year	0.03	0.04
1 year	0.03	0.04
3 years	0.03	0.04
5 years	0.03	0.04
10 years	0.03	0.04

Manager	Title	Age	Since
Johannes Swartling CEO	Chief Executive Officer	54	2025-09-30
Fata Mrsic DFI	Director of Finance/CFO	-	2026-05-31
Marcelo Soto Thompson CTO	Chief Tech/Sci/R&D Officer	-	2025-10-06

SpectraCure AB Stock Nasdaq Stockholm

Stocks

SPEC BTU

SE0029630789

Advanced Medical Equipment & Technology

Valuation: SpectraCure AB

Chart: SpectraCure AB

Latest news : SpectraCure AB

Press Releases: SpectraCure AB

Quotes and Performance

Course Extremes

Managers and Directors: SpectraCure AB

Laser Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Director	Title	Age	Since
Masoud Khayyami BRD	Director/Board Member	63	2012-08-30
Thomas Kramar BRD	Director/Board Member	72	2021-12-31
Jörgen Wennberg CHM	Chairman	74	2021-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPECTRACURE AB	+1.48%	-15.17%	-	-	2.15M
EL.EN. S.P.A.	-0.38%	-3.10%	+32.37%	+53.44%	1.45B
APPLIED ENERGETICS, INC.	0.00%	+4.17%	-32.80%	-48.13%	280M
MODULIGHT OYJ	-1.83%	-3.60%	-12.30%	-47.80%	52.63M
Average	-0.18%	+0.87%	-4.24%	-14.17%	594.04M
Weighted average by Cap.	-0.36%	-0.62%	+20.81%	+34.49%

	2024	2025
Net sales	-	-
Net income	-23M -2.42M -2.09M -1.96M -1.79M -3.36M -231M -3.41M -8.99M -116M -9.08M -8.88M -385M	-56.08M -5.9M -5.09M -4.79M -4.35M -8.18M -564M -8.32M -21.93M -282M -22.14M -21.66M -938M
Net Debt	-13.13M -1.38M -1.19M -1.12M -1.02M -1.92M -132M -1.95M -5.13M -66.11M -5.18M -5.07M -220M	-10.74M -1.13M -975K -916K -833K -1.57M -108M -1.59M -4.2M -54.06M -4.24M -4.15M -180M